ALS News Today21h
Medicare Advantage plans in US told to cover Qalsody for SOD1-ALS
The Centers for Medicare and Medicaid Services is directing all Medicare Advantage plans to cover Qalsody for treating ...
STAT5d
They agreed to cover a drug for six months — and now I have to fight for it again
Shelby Kinsey lives with a rare, fast-progressing form of ALS — but she has to spend her precious time fighting for insurance ...
CMS says private Medicare plans can’t automatically deny Biogen’s ALS drug
In a rare move, the U.S. agency behind Medicare is warning Medicare Advantage providers they can’t have blanket policies that ...
Medpage Today on MSN2d
Detecting Alzheimer's Risks; Migraine and GI Disorders; CJD Glymphatic Dysfunction
(JAMA Neurology) CMS issued a directive requiring Medicare Advantage plans to provide access to tofersen (Qalsody), a ...
Private Medicare plans must cover Biogen's ALS drug, US agency says
The Centers for Medicare & Medicaid Services has directed private insurers providing Medicare Advantage plans to cover Biogen ...
Longview News-Journal8d
Groundbreaking Directive Ensures ALS Patients on Medicare Advantage Gain Access to Qalsody
Dec. 11, 2024 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) has announced a first-of-its-kind directive requiring Medicare Advantage plans to approve coverage for Qalsody ...